iRhythm Technologies (IRTC) News Today

iRhythm Technologies (NASDAQ: IRTC) saw its stock price rise today amid a flurry of analyst upgrades and strong Q2 results that beat expectations and led management to raise full-year guidance.

• Positive Sentiment: JPMorgan upgraded its rating to “overweight” and raised its price target on IRTC from $145 to $190, implying a 15.2% upside from the prior price. Benzinga
• Positive Sentiment: Wells Fargo lifted its price target from $130 to $180 and maintained an “overweight” rating, signaling confidence in iRhythm’s growth trajectory. Benzinga
• Positive Sentiment: Canaccord Genuity raised its price target from $139 to $170 and reiterated a “buy” rating, reflecting optimism after the company’s recent performance. Benzinga
• Positive Sentiment: Needham & Company boosted its price target from $151 to $180 and maintained a “buy” rating, aligning with peers on a strong outlook for IRTC. Benzinga
• Positive Sentiment: William Blair’s Brandon Vazquez reaffirmed a Buy rating on IRTC, citing the company’s strong performance and growth potential. TipRanks
• Positive Sentiment: iRhythm reported Q2 revenue of $186.7 million (up 26.1% year-over-year), beat EPS estimates of ($0.53) with a ($0.32) loss per share, and raised full-year 2025 revenue guidance to $720–$730 million, underscoring operational momentum. GlobeNewswire
• Neutral Sentiment: Full Q2 earnings call transcripts were published (InsiderMonkey, GuruFocus, Seeking Alpha), providing detailed management commentary but no material surprises beyond the press release. InsiderMonkey Transcript